Your browser doesn't support javascript.
loading
Epidermal growth factor receptor (EGFR) is an independent adverse prognostic factor in esophageal adenocarcinoma patients treated with cisplatin-based neoadjuvant chemotherapy.
Aichler, Michaela; Motschmann, Martin; Jütting, Uta; Luber, Birgit; Becker, Karen; Ott, Katja; Lordick, Florian; Langer, Rupert; Feith, Marcus; Siewert, Jörg Rüdiger; Walch, Axel.
Afiliação
  • Aichler M; Research Unit Analytical Pathology- Institute of Pathology, Helmholtz Zentrum München, German Research Center for Environmental Health, Ingolstaedter Landstraße 1, Neuherberg, Germany.
  • Motschmann M; Research Unit Analytical Pathology- Institute of Pathology, Helmholtz Zentrum München, German Research Center for Environmental Health, Ingolstaedter Landstraße 1, Neuherberg, Germany.
  • Jütting U; Institute of Computational Biology, Helmholtz Zentrum München, German Research Center for Environmental Health, Ingolstaedter Landstraße 1, Neuherberg, Germany.
  • Luber B; Institute of Pathology, Technische Universität München, Trogerstraße 18, München, Germany.
  • Becker K; Institute of Pathology, Technische Universität München, Trogerstraße 18, München, Germany.
  • Ott K; Department of Surgery, University Hospital of Heidelberg, Im Neuenheimer Feld 110, Heidelberg, Germany.
  • Lordick F; University Cancer Center Leipzig, University Clinic Leipzig, Liebigstraße 20, Leipzig, Germany.
  • Langer R; Institute of Pathology, Technische Universität München, Trogerstraße 18, München, Germany.
  • Feith M; Department of Surgery, Klinikum rechts der Isar, Technische Universität München, Ismaninger Straße 22, München, Germany.
  • Siewert JR; Directorate, University of Freiburg, Hugstetter Straße 55, 79106 Freiburg, Germany.
  • Walch A; Research Unit Analytical Pathology- Institute of Pathology, Helmholtz Zentrum München, German Research Center for Environmental Health, Ingolstaedter Landstraße 1, Neuherberg, Germany.
Oncotarget ; 5(16): 6620-32, 2014 Aug 30.
Article em En | MEDLINE | ID: mdl-25216514
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Receptores ErbB Tipo de estudo: Prognostic_studies Idioma: En Revista: Oncotarget Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Receptores ErbB Tipo de estudo: Prognostic_studies Idioma: En Revista: Oncotarget Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Alemanha